Atlas Trials

Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL

Clinical trial NCT06481241 · RECRUITING

Trial details

NCT number
NCT06481241
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Philadelphia Chromosome Negative ALLAcute Lymphoblastic Leukemia, Adult
Start date
2024-06-10
Primary completion
2026-06-01
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.